Sleep rehabilitation may restore inflammation resolution needed for autonomic recovery
In menopause, sleep rehabilitation may restore inflammation-resolving capacity before hot-flash suppression can improve autonomic recovery. The mechanism would be rejected if verified disruption of the relevant resolution pathway preserved the benefit of sleep-first treatment
Stage of verification
- Hypothesis published2026-10-03
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Lipid
Specialized pro-resolving lipid mediators
Lipid mediators whose production supports the resolution of inflammatory activity
Where this hypothesis actsAfter repeated sleep disruption in natural and induced menopause
Hypotheses on this target 2
Lower level
Neutralisation
Supplementation1
Composition restoration
What is proposed
Restore production sufficiently to recover functional resolution capacity
With whatChange of environment or regimen
HowSleep rehabilitation before vasomotor suppression; pathway rescue is proposed in a parallel animal experiment
Possible result
Possible autonomic benefit from subsequent vasomotor suppression, persisting after treatment until renewed disturbance
From the recordRepeated sleep disruption depresses the enzymatic production of specialized pro-resolving lipid mediators
Rhythm or programme
Sleep continuity
The sustained, uninterrupted character of sleep
Where this hypothesis actsRepeated sleep disruption in natural and induced menopause
Hypotheses on this target 3
Inhibition
Activation
Function preservation
Feedback restoration
Rhythm restoration3
Direct measurement
What is proposed
Rhythm restoration
Rehabilitate sleep before beginning vasomotor suppression
With whatNot stated in the record
HowSleep rehabilitation with a lead-in long enough to restore functional resolution capacity; the rehabilitation technique is not stated
Possible result
Possible recovery of resolution-lipid production and function before vasomotor suppression
From the recordSleep rehabilitation must precede vasomotor suppression long enough to restore functional resolution capacity
Rhythm or programme
Vasomotor discharges
Episodes of vasomotor activity associated with heat loss
Where this hypothesis actsNatural and induced menopause, after recovery of functional inflammatory resolution capacity
Hypotheses on this target 4- Inhibition4
- Activation
- Function preservation
- Feedback restoration
- Rhythm restoration
- Direct measurement
What is proposed
Inhibition
Suppress vasomotor episodes after functional resolution capacity recovers
With whatNot stated in the record
HowNot stated in the record
Possible result
Possible autonomic recovery once the prerequisite biochemical recovery has occurred
From the recordSleep rehabilitation must precede vasomotor suppression long enough to restore functional resolution capacity
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Better sleep and fewer hot flashes may arrive before the body has recovered from repeated nighttime disturbance. The unexpected move is a proposed waiting period: sleep treatment must first restore the body's ability to bring inflammation to an end before hot flash treatment can deliver lasting recovery. This is a hypothesis generated by the pipeline, not a measured result.
- Repeated sleep disruption is proposed to reduce production of chemical signals that help end inflammation.
- Reduced signal production is proposed to leave inflammation active even after awakenings become less frequent.
- Sleep treatment is proposed to restore the capacity to finish the inflammatory response, changing the body from persistent inflammation to completed recovery.
- That restored capacity is proposed to enable subsequent hot flash suppression to improve automatic bodily regulation; suppression first would leave the unresolved inflammation in place.
- Completed inflammation resolution is proposed to sustain benefit after treatment ends, until renewed disturbance starts another inflammatory episode.
- Recent surgery is proposed to add inflammation that may lengthen the required recovery interval independently of ovarian-hormone loss.
Stopping a leak does not dry a soaked room. The proposal treats improved sleep as restoring the drying equipment, so stopping the remaining leak can finally leave the room dry.
Where the picture breaks: Inflammation is an active biological response, not standing water. The picture cannot establish that sleep restores the relevant signals, that treatment must follow this order, or how long recovery would take.
- Master questionstep 01 of 04
Patterns of symptoms associated with menopause, the end of menstrual cycles following loss of ovarian reproductive function, might reveal knowledge useful for radically extending lifespan.
Rests on: The supplied goal is to connect discovery of menopause-related symptom patterns with radical lifespan extension.
Stated in the chain - Goal pillarstep 02 of 04
The intended outcome is a validated way to identify menopause-related symptom patterns and a treatment protocol with durable effects on lifespan.
Rests on: The master question explicitly seeks menopause-related discoveries that could inform lifespan extension.
Stated in the chain - Gap questionstep 03 of 04
The order of sleep treatment and hot flash suppression might determine recovery of autonomic function, the automatic regulation of bodily processes such as heart activity. The question also concerns what recovery must occur between treatments and whether benefits survive treatment withdrawal in natural menopause and menopause brought on by an intervention.
Rests on: The preceding goal calls for durable treatment, but does not identify sleep, hot flashes or automatic bodily regulation as the route to lifespan extension.
LeapThe supplied chain does not explain why this treatment-order question is the selected route to the lifespan goal or how its recovery outcome would establish an effect on lifespan.
- Hypothesisstep 04 of 04
Sleep treatment is proposed to restore specialized pro-resolving lipid mediators, fat-derived chemical signals that help bring inflammation to an end. Recovery of this process, rather than an early improvement in sleep scores, is proposed to make subsequent hot flash suppression effective and allow benefits to persist after treatment stops.
Rests on: The preceding question supplies the search for a prerequisite recovery process and a durable effect. The hypothesis supplies inflammation resolution, the active process that brings an inflammatory response to an end, as its proposed explanation.
AssumptionThe working premise is that repeated sleep disruption impairs production of these signals and that restoring their function is necessary for the proposed treatment-order benefit. Neither the preceding stages nor the screened sources establish that premise; its status here is a proposed mechanism.
What is carried, and what is not. Among the eight supplied screened sources, none establishes a mechanism-specific link in the proposed sequence; they provide background rather than evidence for the required inflammation recovery interval. S4, in the International Journal of Psychophysiology in 2021, reports blunted heart responses to stress in women with menopausal insomnia, meaning persistent difficulty sleeping, but explicitly leaves unresolved whether the altered responses preceded or followed insomnia and does not establish the proposed mechanism or the sequence end to end.S4
Where the reasoning is carried by something unstated · 2
- Gap question. The supplied chain does not explain why this treatment-order question is the selected route to the lifespan goal or how its recovery outcome would establish an effect on lifespan. Establish the missing link before relying on this step.
- Hypothesis. The working premise is that repeated sleep disruption impairs production of these signals and that restoring their function is necessary for the proposed treatment-order benefit. Neither the preceding stages nor the screened sources establish that premise; its status here is a proposed mechanism.
How a result here could mislead · 3
- A rise in measured fat-derived signals could be mistaken for restored ability to end inflammation, particularly when the signals are scarce or incorrectly identified. What closes it: The proposed test requires both rigorously validated identification of the signals and an ex vivo resolution-function assay, a test of inflammation-ending activity in a sample outside the body. The criteria for recovery and the automatic bodily function outcome must be specified before interpreting their timing; the supplied material gives no thresholds.
- Benefit appearing after inflammation recovery could be credited to that recovery even if improved heat disposal or a changed gut microbial community produced both. Similar sleep improvement and hot flash suppression alone would not separate these explanations. What closes it: The proposed animal experiment must verify that blocking the targeted process preserves sleep improvement and that restoring the process actually restores its function. Heat balance and the establishment and activity of transferred gut microbes must be checked before failed cooling or microbial transfer is treated as evidence against those rivals; the supplied design does not specify these checks.
- A longer recovery interval after intervention-induced menopause could be attributed to ovarian-hormone loss when it instead reflects recent surgery and its associated inflammation. What closes it: Surgical history, timing and inflammation must be measured separately from ovarian-hormone loss, with comparisons that can distinguish their contributions. The proposal states this requirement but supplies no comparison groups or measurement schedule.
What would make this wrong. The proposed requirement would fail if lasting recovery of automatic bodily regulation reliably occurred before restoration of both the chemical signals and measured inflammation-ending function. In the animal test, preserved benefit despite verified selective disruption of the relevant process, with sleep improvement retained, would contradict its claimed necessity. Failure of a verified restoration of that process to bypass the sleep-first interval would separately contradict the proposed rescue prediction.
What it would change. If the hypothesis held, discovery of menopause-related symptom patterns would need to distinguish early symptom relief from restoration of the body's ability to end inflammation, and treatment order would depend on that recovery. This would identify a candidate prerequisite for durable improvement in automatic bodily regulation. It would still not establish lifespan extension, persistence over an unspecified long period, or transfer of an animal causal result to people experiencing natural or intervention-induced menopause.
Sources read · 8
Menopausal hot flashes: mechanisms, endocrinology, treatment. · The Journal of steroid biochemistry and molecular biology · 2014
“Indeed, it was found that HFs in the second half of the night occurred after the awakenings and arousals, whereas, those in the first half of the night preceded them and could, therefore, trigger them.”
Does not settle: The source does not establish that sleep disruption reduces specialized pro-resolving lipid mediator production, that unresolved inflammation delays autonomic recovery, that sleep rehabilitation must precede vasomotor suppression, how long any prerequisite interval lasts, whether benefits persist after treatment cessation, or how surgical inflammation and ovarian-hormone loss separately affect that interval.
Postmenopausal physiological changes. · Current topics in behavioral neurosciences · 2014
“HFs in the first, but not the second half of the night can produce awakenings and arousals.”
Does not settle: The source does not establish whether repeated sleep disruption impairs specialized pro-resolving lipid mediator production, whether sleep rehabilitation restores inflammation resolution or autonomic function, the required treatment sequence or interval, persistence after treatment cessation, or the separate contribution of recent surgical inflammation versus ovarian-hormone loss.
Acupuncture in Obstetrics and Gynecology. · Obstetrical & gynecological survey · 2019
“There are limited but positive data regarding menopause-related sleep disturbances, depression in pregnancy, and overactive bladder.”
Does not settle: The source does not establish whether sleep disruption impairs specialized pro-resolving lipid mediator production, whether sleep rehabilitation restores inflammation resolution or autonomic function, the required treatment sequence or interval, persistence after treatment cessation, or the separate contribution of recent surgical inflammation versus ovarian-hormone loss in induced menopause.
Physiological responses to acute psychosocial stress in women with menopausal insomnia. · International journal of psychophysiology : official journal of the International Organization of Psychophysiology · 2021
“Women with menopausal insomnia show blunted cardiac responses to stress, suggesting alterations in the autonomic reactivity to acute stress. Whether these alterations are pre-existing or are a consequence of insomnia, needs to be determined.”
Does not settle: The source does not establish that sleep disruption impairs specialized pro-resolving lipid mediator production, that sleep rehabilitation restores inflammation resolution or autonomic recovery, the required treatment sequence or interval, persistence after treatment cessation, effects of vasomotor suppression, or separate effects of recent surgical inflammation and ovarian-hormone loss.
Extended wakefulness: compromised metabolics in and degeneration of locus ceruleus neurons. · The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
“We propose that sleep serves a vital function for LCns, and potentially other neuronal groups, in restoring mitochondrial metabolic homeostasis following wakefulness, thereby allowing normal function across normal periods of wakefulness.”
Does not settle: The source does not establish effects of sleep disruption or rehabilitation on specialized pro-resolving lipid mediator production, inflammation resolution, autonomic recovery, vasomotor suppression sequencing, persistence after treatment cessation, or differences between recent surgical inflammation and ovarian-hormone loss.
[The role of TLR4/NF-κB signaling pathway in sleep deprivation induced Meniere's disease]. · Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2023
“Sleep disorders may activate TLR4/NF-κB signaling pathway to induce MD.”
Does not settle: This source does not establish effects of repeated sleep disruption or rehabilitation on specialized pro-resolving lipid mediator production, inflammation-resolution capacity, autonomic recovery, treatment sequencing or duration, persistence after treatment cessation, vasomotor suppression, induced menopause, or surgical inflammation.
Hypertension and atrial fibrillation in obstructive sleep apnea: Is it a menopause issue? · Maturitas · 2019
“These consequences of OSA are associated with a cascade of cardiovascular and neurohumoral consequences, including sympathetic nervous system hyperactivity, raised heart rate variability, increases in blood pressure, myocardial wall stress, oxidative stress, systemic inflammation, platelet aggregation and impaired vascular endothelial function”
Does not settle: The abstract does not establish impaired production or recovery of specialized pro-resolving lipid mediators, the required duration or sequencing of sleep rehabilitation and vasomotor suppression, persistence after treatment cessation, or separate effects of surgical inflammation and ovarian-hormone loss in induced menopause.
Cardiovascular Disease in Women Across the Lifespan: The Importance of Sleep. · Journal of women's health (2002) · 2020
“The proposed pathways linking sleep disturbances and adverse cardiovascular outcomes in women are numerous and the complex interaction between them is not well understood.”
Does not settle: The abstract does not establish effects of repeated sleep disruption on specialized pro-resolving lipid mediator production, the required sequencing or duration of sleep rehabilitation and vasomotor suppression, autonomic recovery or persistence after treatment cessation, or whether recent surgical inflammation alters recovery independently of ovarian-hormone loss.
The gap this hypothesis explains
Nothing is known here: the question has not been asked of this system.
During menopause, should sleep treatment precede, follow, or accompany hot-flash treatment for lasting recovery of automatic body regulation?
Original wording · exactly as the pipeline generated it
Should sleep rehabilitation precede, follow, or accompany vasomotor suppression; what response must precede benefit from the second action, and does autonomic recovery persist after treatment ends across natural and induced menopause?
What this question is asking
The question concerns whether the order of treating sleep problems and hot flashes changes how well symptoms and automatic body regulation recover around menopause. It compares sleep treatment first, hot-flash treatment first, and both together, asking whether a particular improvement must occur before the second treatment can help. It also asks whether improved regulation remains after treatment stops and any lingering treatment effects have worn off, and whether this differs between menopause occurring naturally and menopause brought on by medical treatment. The pipeline assumes that a treatment sequence could restore sleep within nights to weeks and prevent worsening of automatic body regulation, while asserting that the necessary order, prerequisite response, and lasting benefit have not been established.
- Menopause
- The end of menstrual cycles associated with the end of ovarian reproductive function. The question concerns symptoms and regulation around this transition and afterward.
- Natural and induced menopause
- Natural menopause occurs without a medical intervention bringing it about; induced menopause is brought on by medical treatment. These are broad categories, and the supplied evidence does not establish that everyone within either category responds alike.
- Surgical menopause
- Menopause caused by surgical removal of both ovaries, a form of induced menopause. S3 excludes this group.
- Perimenopause or menopausal transition
- The period of change around the final menstrual period. Findings limited to this stage do not automatically establish what happens in other stages or after induced menopause.
- Sleep rehabilitation or sleep treatment
- Actions intended to improve disrupted sleep. The pipeline uses this as a broad treatment category without specifying a particular intervention or a criterion for restored sleep.
- Insomnia
- Difficulty falling asleep, staying asleep, or obtaining satisfactory sleep despite an opportunity to sleep. It identifies the sleep problem in the group studied in S9.
- Hot flashes and vasomotor symptoms
- Hot flashes are episodes of heat sensation; vasomotor symptoms is the clinical grouping that includes hot flashes and night sweats. Vasomotor suppression means reducing these symptoms, without specifying how.
- Autonomic regulation, deterioration, and recovery
- Autonomic regulation is the nervous system's largely automatic control of bodily functions, including heart activity. Deterioration and recovery would mean worsening and improvement in that control, but the supplied material provides no agreed measurement or threshold for either.
- Residual exposure
- Treatment exposure that remains after administration stops, such as a drug still present in the body. The question seeks benefit that continues beyond lingering treatment effects.
- Prerequisite response
- An improvement that must occur before another treatment can provide benefit. An improvement happening first in time would not, by itself, establish that it was necessary.
- Suvorexant
- The drug named in S8's treatment finding. The supplied quote reports a reduction in nighttime vasomotor symptoms but does not establish its mechanism or its place in a two-treatment sequence.
- Blunted heart response to stress
- A smaller or less pronounced change in heart activity during stress. S9 reports this pattern, but the supplied excerpt does not identify the precise measurement or establish that reversing it constitutes recovery.
- Population studies and laboratory investigations
- Population studies examine patterns among groups of people; laboratory investigations examine responses under controlled study conditions. S7 reports differing findings from these approaches without supplying enough detail to resolve them.
- Self-reported symptom frequency
- How often symptoms occur according to participants' own reports. This is the nighttime outcome reported in the supplied S8 quote.
- Depression and cognitive difficulties
- Depression concerns persistent disturbances of mood and related functioning; cognitive difficulties concern abilities such as attention, memory, and thinking. S3 reports possible associations involving these problems, sleep, and vasomotor symptoms rather than establishing a causal sequence.
An executable sequence restores sleep within nights to weeks, prevents autonomic deterioration, and retains benefit beyond residual exposure; a response to the first action is required before benefit from the second, and no validated origin-specific restorative sequence exists.
The two actions are treatment of sleep problems and treatment of hot flashes; the proposed additional outcome is recovery of the body's automatic regulation, including its control of heart activity. The framing assumes that these actions can form a lasting recovery sequence, potentially with an improvement that must happen before the next action works, and that the sequence may differ between naturally occurring and medically induced menopause. If established, those assumptions would make treatment order and the response between treatments meaningful determinants of recovery.
The supplied sources do not establish this sequence, its proposed prerequisite, or lasting recovery. S8 reports fewer self-reported nighttime vasomotor symptoms during suvorexant treatment, while S9 reports altered heart responses to stress in women with menopausal insomnia; neither establishes a treatment pathway connecting those findings. S5 and S7 also differ on whether hot flashes cause disturbed sleep. The absence of a validated sequence in these supplied excerpts does not establish that no such sequence exists anywhere in the literature, and the pipeline's treatment-readiness classifications are not substantiated by the supplied material.S5S7S8S9
The same question asked without the part nothing read establishes:
- In natural and medically induced menopause, how do sleep treatment first, hot-flash treatment first, and concurrent treatment compare for sleep improvement, automatic body regulation, and persistence after treatment effects have worn off?
- Does benefit from sleep treatment or hot-flash treatment depend on a prior response to the other treatment, and does that relationship differ between natural and medically induced menopause?
- Sleep treatment first If sleep improvement is necessary before hot-flash treatment provides additional benefit, sleep would be the first treatment target in a dependent sequence. That result would establish an order only for the outcomes actually measured; lasting recovery of automatic body regulation would still require evidence after treatment effects have worn off.
- Hot-flash treatment first If reducing hot flashes removes a cause of disturbed sleep and that change is necessary for subsequent sleep treatment to help, hot-flash control would come first. This outcome would make hot-flash reduction a prerequisite for the second action in the studied setting, without establishing that all sleep problems arise from hot flashes.
- Both treatments together If neither treatment requires a prior response to the other and concurrent treatment produces the relevant benefit, no waiting response would be needed between them. Improvement during combined treatment would still leave open whether automatic body regulation remains improved after both treatments end.
- No single restorative order If the orders produce similar outcomes, differ by how menopause began, or fail to produce lasting recovery, a universal sequence would not be supported. Symptom relief could still occur without establishing the proposed chain from treatment order to durable recovery.
The proposed chain runs from treatment order, through improvement in sleep or hot flashes, to recovery of automatic body regulation and continued benefit after treatment ends. Each link needs separate support: a reduction in symptoms does not by itself establish recovery of the underlying regulation. If benefit from one treatment depends on an earlier response to another, changing the order could change the result; if no such dependency exists, requiring that order would impose an unsupported restriction. Likewise, improvement while treatment remains active cannot establish that recovery persists afterward. The supplied evidence does not connect any of these outcomes to longer lifespan.
RL-3 component treatments and follow-up methods coexist with an RL-1 sequencing framework; no validated origin-specific restorative sequence exists.
An executable sequence restores sleep within nights to weeks, prevents autonomic deterioration, and retains benefit beyond residual exposure.
The required first action, causal prerequisite for the next action, and persistence after cessation have not been experimentally established.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Repeated sleep disruption depresses the enzymatic production of specialized pro-resolving lipid mediators, leaving inflammatory activity unresolved after awakenings become less frequent. Sleep rehabilitation must precede vasomotor suppression long enough to restore functional resolution capacity; that biochemical recovery, rather than the first improved sleep score, enables the second action to improve autonomic recovery. Suppression-first removes a trigger while leaving unresolved inflammation active. Once resolution has completed, autonomic benefit can persist after cessation until renewed disturbance initiates another inflammatory episode. Recent surgical inflammation may prolong the prerequisite interval in induced menopause, but this must be measured separately from ovarian-hormone loss.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
Among participants with comparable objective sleep improvement and flash suppression, autonomic benefit begins only after recovery of both validated resolution-lipid production and an ex vivo resolution-function assay. In a parallel animal experiment, selectively disrupting the relevant resolution pathway abolishes benefit from sleep-first treatment despite preserved sleep improvement; pathway rescue bypasses the need for the sleep-first lead-in. Cooling alone and transfer of washed microbial communities do not reproduce this rescue.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable onset conditions, loss of benefit after pathway disruption, and contrasting rescue outcomes. No rival prediction is supplied. A paper already fetched for this hypothesis bears on it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Repeated lipidomics and functional immune assays are available, but low-abundance mediator identification requires stringent analytical validation. Human mediation analyses remain provisional; pathway-specific causal tests should be performed preclinically.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
Among participants with comparable objective sleep improvement and flash suppression, autonomic benefit begins only after recovery of both validated resolution-lipid production and an ex vivo resolution-function assay. In a parallel animal experiment, selectively disrupting the relevant resolution pathway abolishes benefit from sleep-first treatment despite preserved sleep improvement; pathway rescue bypasses the need for the sleep-first lead-in. Cooling alone and transfer of washed microbial communities do not reproduce this rescue.
- Rival 01 of 03What would separate them
Suppressing menopausal hot flashes may impair autonomic recovery by preventing heat loss predicts: Under mild nighttime heat, suppression-first reduces objectively recorded flashes but lengthens next-day cardiovascular recovery when it also increases retained heat. Randomized external cooling reverses that deterioration within the same night despite continued flash suppression and without requiring microbial, resolution-lipid or DNA-repair changes. Failure to observe increased retained heat, or failure of adequately delivered cooling to rescue recovery, rejects this mechanism.
- Rival 02 of 03What would separate them
Sleep-first treatment may sustain recovery by changing which gut microbes establish first predicts: After matched treatment exposure and documented washout, durable responders retain a strain-resolved community signature. Washed microbial communities collected after sleep-first treatment transfer improved sleep continuity and cardiovascular recovery to standardized recipient animals, whereas baseline and suppression-first communities do not. Reconstructing the communities with identical strains but reversed establishment order reproduces the difference. Failure of transfer despite verified engraftment, or elimination of the order effect without changing community function, weakens this mechanism in favor of host-intrinsic rivals.
- What would separate them
Repair of genetic damage may enable lasting autonomic recovery after menopause predicts: Simultaneous initiation produces earlier durable autonomic recovery than either sequential order, even after accounting for total component exposure. In a menopausal animal model, transient tissue-specific impairment of DNA repair during otherwise successful joint treatment prevents later autonomic recovery without preventing initial sleep improvement. Restoring repair restores benefit. The effect remains after controlling temperature, microbial community and resolution-lipid status; normal recovery despite verified persistent lesions rejects the proposed repair prerequisite.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. 5 paper(s) already retrieved for this hypothesis carry its prediction’s terms. Reading them comes before running anything. Already retrieved: Pleiotropic Bioactivity of Caterpillar Fungus, Orange Cordyceps, and Cordycepin: Insight from Integrated Network Pharmacology and Food and Drug Regulatory Framework.; Dietary Polyphenols as Modulators of Redox Signalling: From the Antioxidant-Pro-Oxidant Continuum to Clinical Translation (2015-2025).; Current Challenges and Future Directions in the Assessment of Glucocorticoid Status..
6 papers retrieved around this hypothesis
- Alcohol induces long-lasting sleep deficits in Drosophila via subsets of cholinergic neurons.PMID 39919743 · full_text · 80,151 characters stored
- BMAL1 Dysregulation as a Contributing Mechanism Linking Obesity to Oocyte and Endometrial Dysfunction in IVF.PMID 42794432 · full_text · 161,677 characters stored
- Pleiotropic Bioactivity of Caterpillar Fungus, Orange Cordyceps, and Cordycepin: Insight from Integrated Network Pharmacology and Food and Drug Regulatory Framework.PMID 41901364 · full_text · 240,526 characters stored
- Dietary Polyphenols as Modulators of Redox Signalling: From the Antioxidant-Pro-Oxidant Continuum to Clinical Translation (2015-2025).PMID 42510972 · full_text · 179,449 characters stored
- Current Challenges and Future Directions in the Assessment of Glucocorticoid Status.PMID 38795365 · full_text · 153,943 characters stored
- Special Collection: Abstracts from IUNS-ICN Paris 2025europepmc:PMC:PMC13439031 · abstract_only · 54 characters stored
0 citation handles extracted; 1 Europe PMC search run; 8 records examined; 6 sources stored for enrichment, 5 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.